OKYO
OKYO
NASDAQ · Biotechnology

Okyo Pharma Ltd

$1.35
-0.05 (-3.57%)
As of Nov 14, 10:44 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,040.0% upside
Low Target $16.92
Average Target $28.89
High Target $30.86
Current Price $1.35
Current
$1.35
Target
$28.89
$16.92 $28.89 avg $30.86
Scenario Analysis
Bear Case
$16.92
1,153.3%
Low target
Base Case
$28.89
+2,040.0%
Avg target
Bull Case
$30.86
+2,185.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.20
-57.8% from high
52-Week Low
$1.26
+6.7% from low
Target vs 52W High
$28.89
+802.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%